SCHEMBL7436381

SCHEMBL7436381

NCCCCCCCCCCC(C(=O)O)C(=O)CN

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSR P00390 1/20 0.54
RNPEP Q9H4A4 1/20 0.52
CPB2 Q96IY4 7/20 0.52
MEN1 O00255 1/20 0.43
ALDH1A1 P00352 1/20 0.43
PLG P00747 1/20 0.43
LMNA P02545 1/20 0.43
THRB P10828 1/20 0.43
ALOX15 P16050 1/20 0.43
SLC6A2 P23975 1/20 0.43
RECQL P46063 1/20 0.43
SLC6A3 Q01959 1/20 0.43
KMT2A Q03164 1/20 0.43
FOLH1 Q04609 1/20 0.41
CYP2D6 P10635 1/20 0.39
NFKB1 P19838 1/20 0.39
BLM P54132 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
DPP7 Q9UHL4 2/20 0.38
DPP4 P27487 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8519056 0.98 GSR (0.56) GSRRNPEPCPB2MEN1ALDH1A1
SCHEMBL28958754 0.91 GSR (0.46) GSRRNPEPCPB2MEN1ALDH1A1
SCHEMBL7457362 0.86 GSR (0.62) GSRRNPEPCPB2MEN1ALDH1A1
SCHEMBL15869626 0.86 GSR (0.62) GSRRNPEPCPB2MEN1ALDH1A1
SCHEMBL15869565 0.86 GSR (0.62) GSRRNPEPCPB2MEN1ALDH1A1
SCHEMBL15869606 0.86 GSR (0.62) GSRRNPEPCPB2MEN1ALDH1A1
SCHEMBL6014002 0.86 GSR (0.62) GSRRNPEPCPB2MEN1ALDH1A1
SCHEMBL15869673 0.86 GSR (0.62) GSRRNPEPCPB2MEN1ALDH1A1
SCHEMBL1009663 0.86 GSR (0.62) GSRRNPEPCPB2MEN1ALDH1A1
SCHEMBL29367483 0.85 LMNA (0.52) GSRRNPEPCPB2MEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0725797-B1 BIVALENT THROMBIN INHIBITORS CA NAT RESEARCH COUNCIL (CA) 2001-01-10 EP claimed
WO-1996030407-A1 BIFUNCTIONAL THROMBIN INHIBITORS BEARING HIGHLY TRUNCATED FIBRINOGEN RECOGNITION EXOSITE BINDING COMPONENT NATIONAL RESEARCH COUNCIL OF CANADA (CA) 1996-10-03 WO claimed
EP-0725797-A1 BIVALENT THROMBIN INHIBITORS NATIONAL RESEARCH COUNCIL OF CANADA (CA) 1996-08-14 EP claimed
WO-1995011921-A1 BIVALENT THROMBIN INHIBITORS NATIONAL RESEARCH COUNCIL OF CANADA (CA) 1995-05-04 WO claimed
EP-0725797-B1 BIVALENT THROMBIN INHIBITORS CA NAT RESEARCH COUNCIL (CA) 2001-01-10 EP disclosed
US-6127337-A BASED ON HIRUDIN BUT WITH REDUCED SIZE; ACTIVE SITE INHIBITOR SEGMENT SUBSTITUTED BY SMALL NON-SUBSTRATE TYPE ACTIVE SITE INHIBITORS OF THROMBIN, SUCH AS DANSYL-ARG-(D-PIPECOLIC ACID); LINKER AND FIBRINOGEN RECOGNITION EXOSITE PORTION NATIONAL RESEARCH COUNCIL OF CANADA (CA) 2000-10-03 US disclosed
WO-1996030407-A1 BIFUNCTIONAL THROMBIN INHIBITORS BEARING HIGHLY TRUNCATED FIBRINOGEN RECOGNITION EXOSITE BINDING COMPONENT NATIONAL RESEARCH COUNCIL OF CANADA (CA) 1996-10-03 WO disclosed
EP-0725797-A1 BIVALENT THROMBIN INHIBITORS NATIONAL RESEARCH COUNCIL OF CANADA (CA) 1996-08-14 EP disclosed
WO-1995011921-A1 BIVALENT THROMBIN INHIBITORS NATIONAL RESEARCH COUNCIL OF CANADA (CA) 1995-05-04 WO disclosed